• Experimental and topological determination of the pressure-temperature phase diagram of morniflumate, a pharmaceutical ingredient with anti-inflammatory properties

Data

[{'id': 116638, 'desc': '1 datapoints in 1 series, <b>quantities:</b> Normal melting temperature, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}, {'id': 116639, 'desc': '1 datapoints in 1 series, <b>quantities:</b> Molar enthalpy of transition or fusion, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}, {'id': 116640, 'desc': '1 datapoints in 1 series, <b>quantities:</b> Triple point temperature, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}, {'id': 116641, 'desc': '9 datapoints in 1 series, <b>quantities:</b> Solid-liquid equilibrium temperature, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}, {'id': 116642, 'desc': '19 datapoints in 1 series, <b>quantities:</b> Specific volume, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}, {'id': 116643, 'desc': '17 datapoints in 1 series, <b>quantities:</b> Mass density, <b>system:</b> 2-morpholinoethyl 2-((3-(trifluoromethyl)phenyl)amino)nicotinate'}] temp"